Launch 29 Jan 2026 · costs from the KID as of 2 Sept 2026 · 475 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Sub-Fund is passively managed. The objective of the Sub- Fund is to track the performance of the MSCI India Investable Market Index (the "Index"). The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is an equity index representative of the large- , mid-cap markets and small cap segments of the Indian market. The index covers approximately more than 90% of the free float-adjusted market capitalization of the Indian equity universe. Only ordinary shares are eligible for…
Performance since series start (in euro) — base 100
19 Jan 2026 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 102 (10 Feb 2026) · low 88 (31 Mar 2026) · last 98. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/IE000DVPTMD5 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.